Unlocking Hope for Cancer Patients Using PDT
MARKET OVERVIEW
$0.005
(@ 28 February 2024)
Market Cap
A$32.1m
$0.008
$0.007
$0.006
$0.005
Focus
Clinical-stage life
sciences company
developing the
PhotosoftTM technology as
a treatment for a range
of diseases including
cancers
Issued Shares
Cash
(@ 31 December 2023)
Revenue
(Year ended 30 June 2023)
Symbol/ Exchange
1-Year Price and Volume
Mar
Apr May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2024
Feb
Source: Market Index
Top 10 Shareholders
%
POLAR VENTURES LIMITED
8.49
6.4 B
BNP PARIBAS NOMINEES PTY LTD <IB AU NOMS RETAILCLIENT DRP>
RMW CHO HEALTH TECHNOLOGY LIMITED
RMWC PTY LTD <RMWC FAMILY A/C>
8.33
5.01
4.90
MR HONSUE CHO
4.43
AUD $1.9M
NGPDT GREATER CHINA LIMITED
4.25
MEI JUN LIN
4.24
$4.1M
ACSLNC PTY LTD <ACSLNC FAMILY A/C>
3.50
CITICORP NOMINEES PTY LIMITED
2.53
SUREFIT CAPITAL PTY LTD
2.34
ASX: IVX
TOTAL
48.02
27
27 Next Generation Photodynamic Therapy | March 2024
INVIONView entire presentation